CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS € in Thousands	12 Months Ended		24 Months Ended
	Dec. 31, 2021 EUR (€) shares	Dec. 31, 2021 $ / shares	Dec. 31, 2020 EUR (€) shares	Dec. 31, 2020 $ / shares
Revenues
Research and development services	€ 3		€ 35
Grants	427		633
Total revenues	430		668
Expenses
Research and development	975		1,055
General and administrative	1,105		1,187
Total expenses	2,080		2,242
Operating loss	1,650		1,574
Interest expense	2,751		2,708
Other (income) expense	329		(124)
Loss before income tax provision	(4,730)		(4,158)
Income tax provision	0		0
Net loss	(4,730)		(4,158)
Other Comprehensive Loss
Foreign currency translation adjustment	(4)		4
Comprehensive loss	€ (4,734)		€ (4,154)
Basic and diluted loss per share | $ / shares		$ (0.02)		$ (0.01)
Weighted average number of shares used in per share calculations | shares	303,757,622		303,757,622